ANTI-ADALIMUMAB ANTIBODIES (ADL) - ANVISA Registration 10350840429

Access comprehensive regulatory information for ANTI-ADALIMUMAB ANTIBODIES (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840429 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including IMMUNDIAGNOSTIK, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
10350840429
Registration Details
ANVISA Registration Number: 10350840429
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família AFIAS Free Anti-Adalimumab
Risk Class II

Registration Details

10350840429

25351420179202282

02220795000179

Company Information

BODITECH MED INC.
South Korea
PT: CORÉIA DO SUL

Dates and Status

Nov 07, 2022

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTI-ADALIMUMAB ANTIBODIES (ADL)"